vs

Side-by-side financial comparison of Bowhead Specialty Holdings Inc. (BOW) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

Bowhead Specialty Holdings Inc. is the larger business by last-quarter revenue ($151.7M vs $150.6M, roughly 1.0× GLAUKOS Corp). Bowhead Specialty Holdings Inc. runs the higher net margin — 9.8% vs 6.2%, a 3.6% gap on every dollar of revenue.

Bowhead Specialty Holdings Inc. is a specialty insurance holding company that offers a diversified portfolio of property and casualty insurance products, focusing on underserved niche market segments primarily across North America. It provides tailored risk management solutions and specialized coverage options for both commercial and individual clients.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

BOW vs GKOS — Head-to-Head

Bigger by revenue
BOW
BOW
1.0× larger
BOW
$151.7M
$150.6M
GKOS
Higher net margin
BOW
BOW
3.6% more per $
BOW
9.8%
6.2%
GKOS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BOW
BOW
GKOS
GKOS
Revenue
$151.7M
$150.6M
Net Profit
$14.8M
$9.4M
Gross Margin
77.9%
Operating Margin
11.7%
9.0%
Net Margin
9.8%
6.2%
Revenue YoY
41.2%
Net Profit YoY
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOW
BOW
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$151.7M
$143.1M
Q3 25
$143.9M
$133.5M
Q2 25
$133.3M
$124.1M
Q1 25
$122.7M
$106.7M
Q4 24
$105.5M
Q3 24
$116.8M
$96.7M
Q2 24
$98.9M
$95.7M
Net Profit
BOW
BOW
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$14.8M
$-133.7M
Q3 25
$15.2M
$-16.2M
Q2 25
$12.3M
$-19.7M
Q1 25
$11.4M
$-18.1M
Q4 24
$-33.6M
Q3 24
$12.1M
$-21.4M
Q2 24
$5.5M
$-50.5M
Gross Margin
BOW
BOW
GKOS
GKOS
Q1 26
77.9%
Q4 25
-1.1%
Q3 25
78.4%
Q2 25
78.3%
Q1 25
77.2%
Q4 24
72.9%
Q3 24
76.6%
Q2 24
76.4%
Operating Margin
BOW
BOW
GKOS
GKOS
Q1 26
9.0%
Q4 25
11.7%
-97.7%
Q3 25
13.3%
-12.3%
Q2 25
11.9%
-18.3%
Q1 25
11.8%
-19.4%
Q4 24
-27.2%
Q3 24
13.5%
-25.5%
Q2 24
7.5%
-31.3%
Net Margin
BOW
BOW
GKOS
GKOS
Q1 26
6.2%
Q4 25
9.8%
-93.4%
Q3 25
10.5%
-12.2%
Q2 25
9.3%
-15.8%
Q1 25
9.3%
-17.0%
Q4 24
-31.8%
Q3 24
10.4%
-22.1%
Q2 24
5.6%
-52.8%
EPS (diluted)
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
$0.44
$-2.34
Q3 25
$0.45
$-0.28
Q2 25
$0.36
$-0.34
Q1 25
$0.34
$-0.32
Q4 24
$-0.56
Q3 24
$0.36
$-0.39
Q2 24
$0.20
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOW
BOW
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$193.5M
$276.7M
Total DebtLower is stronger
$146.4M
Stockholders' EquityBook value
$448.3M
$670.9M
Total Assets
$2.4B
$893.3M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOW
BOW
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$193.5M
$90.8M
Q3 25
$197.9M
$98.2M
Q2 25
$114.8M
$100.8M
Q1 25
$88.0M
$114.3M
Q4 24
$169.6M
Q3 24
$132.9M
$100.1M
Q2 24
$180.3M
$68.1M
Total Debt
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
$146.4M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
BOW
BOW
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$448.3M
$656.2M
Q3 25
$430.2M
$769.5M
Q2 25
$407.2M
$765.1M
Q1 25
$391.0M
$764.0M
Q4 24
$766.9M
Q3 24
$364.7M
$668.5M
Q2 24
$339.9M
$665.2M
Total Assets
BOW
BOW
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$2.4B
$893.5M
Q3 25
$2.1B
$999.4M
Q2 25
$1.9B
$987.0M
Q1 25
$1.8B
$966.2M
Q4 24
$974.8M
Q3 24
$1.5B
$926.5M
Q2 24
$1.4B
$919.7M
Debt / Equity
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOW
BOW
GKOS
GKOS
Operating Cash FlowLast quarter
$331.6M
Free Cash FlowOCF − Capex
$326.0M
FCF MarginFCF / Revenue
214.9%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
22.34×
TTM Free Cash FlowTrailing 4 quarters
$593.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
$331.6M
$6.8M
Q3 25
$114.7M
$-10.1M
Q2 25
$109.0M
$7.0M
Q1 25
$47.7M
$-18.5M
Q4 24
$507.0K
Q3 24
$119.4M
$-9.6M
Q2 24
$-18.4M
Free Cash Flow
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
$326.0M
$3.9M
Q3 25
$113.5M
$-11.7M
Q2 25
$107.4M
$5.8M
Q1 25
$46.5M
$-20.5M
Q4 24
$-1.2M
Q3 24
$118.4M
$-11.0M
Q2 24
$-20.5M
FCF Margin
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
214.9%
2.7%
Q3 25
78.8%
-8.8%
Q2 25
80.6%
4.7%
Q1 25
37.9%
-19.2%
Q4 24
-1.2%
Q3 24
101.4%
-11.4%
Q2 24
-21.4%
Capex Intensity
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
3.7%
2.0%
Q3 25
0.9%
1.2%
Q2 25
1.2%
0.9%
Q1 25
1.0%
1.8%
Q4 24
1.6%
Q3 24
0.9%
1.5%
Q2 24
2.2%
Cash Conversion
BOW
BOW
GKOS
GKOS
Q1 26
Q4 25
22.34×
Q3 25
7.56×
Q2 25
8.83×
Q1 25
4.18×
Q4 24
Q3 24
9.88×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons